Connect Biopharma Holdings LtdCNTBEarnings & Financial Report
Nasdaq
NextMar 30, 2026
CNTB Q3 2025 Key Financial Metrics
Revenue
$16.0K
Gross Profit
N/A
Operating Profit
$-17.7M
Net Profit
$-17.2M
Gross Margin
N/A
Operating Margin
-110481.3%
Net Margin
-107500.0%
YoY Growth
N/A
EPS
$-0.31
Financial Flow
Connect Biopharma Holdings Ltd Q3 2025 Financial Summary
Connect Biopharma Holdings Ltd reported revenue of $16.0K for Q3 2025, with a net profit of $-17.2M (-107500.0% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $16.0K |
|---|---|
| Net Profit | $-17.2M |
| Gross Margin | N/A |
| Operating Margin | -110481.3% |
| Report Period | Q3 2025 |
Income Statement
| Q2 2024 | Q2 2025 | Q3 2025 | |
|---|---|---|---|
| Revenue | $24.1M | $48000 | $16000 |
| YoY Growth | N/A | -99.8% | N/A |
Balance Sheet
| Q2 2024 | Q2 2025 | Q3 2025 | |
|---|---|---|---|
| Assets | $120.6M | $82.7M | $67.4M |
| Liabilities | $10.1M | $11.4M | $12.0M |
| Equity | $110.9M | $71.3M | $55.4M |
Cash Flow
| Q2 2024 | Q2 2025 | Q3 2025 | |
|---|---|---|---|
| Operating CF | $-7.7M | $-12.6M | $-17.4M |